MetaCap

iRhythm Financial Ratios

NASDAQ: IRTCHealth CareMedical/Dental InstrumentsUSD

106.70+4.10 (+4.00%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

iRhythm ratio analysis

iRhythm earned a net margin of -6.0% in FY 2025, up from -19.1% a year earlier. Gross margin was 70.6% compared with a median of 68.9% over the prior 9 years. Return on equity reached -29.2%, meaning iRhythm generated -0.29 dollars of profit for every dollar of shareholders' equity.

Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

iRhythm financial ratios (annual)

iRhythm annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Price / sales7.514.796.636.8210.6924.838.0411.1612.792.47
Price / book36.7131.1715.5511.6912.3519.2712.7331.5315.981.70
Gross margin70.6%68.9%67.3%68.5%66.2%73.5%75.5%73.7%71.5%67.4%
Operating margin-7.7%-19.5%-25.4%-27.7%-31.0%-16.5%-25.5%-31.0%-27.8%-24.3%
Net margin-6.0%-19.1%-25.0%-28.3%-31.4%-16.5%-25.4%-34.2%-30.0%-32.6%
Free cash flow margin4.6%-5.2%-18.4%-12.9%-20.4%-10.3%-19.7%-23.3%-18.6%-30.3%
Return on equity (ROE)-29.2%-124.6%-58.7%-48.4%-36.3%-12.8%-40.3%-96.6%-37.5%-22.5%
Return on assets (ROA)-4.4%-12.2%-28.5%-25.9%-21.9%-8.6%-17.8%-42.9%-22.3%-15.1%
Debt / equity—0.000.170.150.080.100.260.670.430.35
Current ratio4.635.822.153.243.485.753.323.445.608.98
Revenue growth26.2%20.1%19.9%27.3%21.7%23.6%45.7%48.6%54.7%77.3%

Related